Serum prostate-specific antigen elevation in the post-radical prostatectomy patient (Q41249092)

28 September 2017

1 reference

title

Serum prostate-specific antigen elevation in the post-radical prostatectomy patient (English)

1 reference

28 September 2017

Malkowicz SB

1

1 reference

28 September 2017

publication date

1 November 1996

1 reference

Urologic Clinics of North America

28 September 2017

published in

1 reference

28 September 2017

volume

23

1 reference

28 September 2017

issue

4

1 reference

28 September 2017

page(s)

665-675

1 reference

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Treatment with finasteride following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Adjuvant radiation therapy in stages C and D1 prostatic adenocarcinoma: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

High-dose bicalutamide monotherapy for the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Overview analysis issues using combined androgen deprivation overview analysis as an example.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Combination finasteride and flutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Definitive radiotherapy following prostatectomy: results and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Adjuvant radiotherapy following radical prostatectomy: results and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Sonographic characteristics of the urethrovesical anastomosis in the early post-radical prostatectomy patient

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

The role of external beam radiation therapy after prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Serum prostate-specific antigen and the biologic progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Value of transrectal ultrasound in identifying local disease after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Prostate Specific Antigen and Local Recurrence after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Megestrol Acetate for the Prevention of Hot Flashes

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

The Clinical Usefulness of Prostate Specific Antigen: Update 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Impact of Radical Prostatectomy in the Management of Clinically Localized Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

A Comparison of 4 Ultrasensitive Prostate Specific Antigen Assays for Early Detection of Residual Cancer after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Current role of MR imaging in the staging of adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Prostatic Specific Antigen Related to Clinical Status 1 to 14 Years after Radical Retropubic Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Recurrent Prostate Cancer Despite Undetectable Prostate Specific Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

The Enhanced Detection of Persistent Disease After Prostatectomy with a New Prostate Specific Antigen Immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Transrectal US in evaluation of patients after radical prostatectomy. Part II. Transrectal US and biopsy findings in the presence of residual and early recurrent prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: Analysis of freedom from psa failure

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970344-X

7 January 2021

10.1016/S0094-0143(05)70344-X

Identifiers

DOI

1 reference

28 September 2017

1 reference